Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel Pin1 inhibitors prepared and tested at Jerini

May 6, 2004

German scientists identify an antitumor and anti-HIV compound from Penicillium species

May 6, 2004

Orphan drug status for PI-88 for malignant melanoma

May 5, 2004

AMDL seeks partner for Combination Immunogene Therapy

May 5, 2004

Panacea collaborates with M.D. Anderson Cancer Center on HAAH program

May 5, 2004

MAGNET liver cancer trial stopped early

May 5, 2004

Interim results from phase II trial of Metastat

May 5, 2004

Celgene to stop Revlimid phase III trials in melanoma

May 4, 2004

New antiangiogenic agents in early development at Boehringer Ingelheim

May 4, 2004

Lilly claims TGF-beta receptor kinase inhibitors for cancer and other disorders

May 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...